Fibrocell Science Inc (FCSC)

[Ned Serious]

Source: Reuters
Link: http://www.reuters.com/article/2012/04/17/idUS217635+17-Apr-2012+BW20120417

LAVIV™ (azficel-T) Pivotal Trial Data Published in Peer-Reviewed Journal, Dermatologic Surgery

-Data Shows Statistically Significant Improvement in Appearance of “Smile Line” Wrinkles-

-------------------------------

An excerpt from the above:

This analysis combined results from two studies and required a 2-point improvement in both patient and investigator wrinkle assessments. Based on this standard, 30% of subjects who received at least one LAVIV injection had a 2-point improvement in the appearance of smile lines six months after completing treatment, as rated by investigators, versus 8% for placebo.

In self-assessments, 59% of patients reported a two-point improvement six months after completing treatment, versus 26% for placebo. See the full prescribing information for LAVIV for results from the each of the two individual studies including the adverse reactions reported in = 1% of subjects. The safety and efficacy of LAVIV for areas other than the nasolabial folds have not been established.